Glycorex Transplantation publ AB (GTABb)

Currency in SEK
2.160
-0.010(-0.46%)
Closed·
GTABb Scorecard
Full Analysis
High return over the last year
GTABb is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.1602.160
52 wk Range
1.1504.400
Key Statistics
Bid/Ask
2.70 / 2.74
Prev. Close
2.13
Open
2.16
Day's Range
2.16-2.16
52 wk Range
1.15-4.4
Volume
55.46K
Average Volume (3m)
32.58K
1-Year Change
55.96%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GTABb Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Neutral

Glycorex Transplantation publ AB Company Profile

Glycorex Transplantation AB (publ), a medical technology company, focuses on transplantation, blood transfusion, and autoimmune diseases. It develops an antigen-specific immunoadsorption to reduce blood group antibodies and autoantibodies in the blood. The company’s principal product is Glycosorb-ABO, which enables blood group incompatible kidney transplantation and is also used to enable heart, liver, lung, and stem cell transplantation procedures. It serves in Europe, Austria, Germany, the Netherlands, the United Kingdom, Canada, and Spain. Glycorex Transplantation AB (publ) was incorporated in 1995 and is headquartered in Lund, Sweden.

Compare GTABb to Peers and Sector

Metrics to compare
GTABb
Peers
Sector
Relationship
P/E Ratio
−18.8x0.0x−0.5x
PEG Ratio
−0.270.000.00
Price/Book
4.2x0.0x2.6x
Price / LTM Sales
4.6x0.0x3.2x
Upside (Analyst Target)
-0.0%38.8%
Fair Value Upside
Unlock0.0%5.4%Unlock

Earnings

Latest Release
May 24, 2025
EPS / Forecast
-0.02 / --
Revenue / Forecast
9.68M / --
EPS Revisions
Last 90 days

GTABb Income Statement

FAQ

What Stock Exchange Does Glycorex Transplantation Trade On?

Glycorex Transplantation is listed and trades on the Nordic Growth Market stock exchange.

What Is the Stock Symbol for Glycorex Transplantation?

The stock symbol for Glycorex Transplantation is "GTABb."

What Is the Glycorex Transplantation Market Cap?

As of today, Glycorex Transplantation market cap is 170.32M.

What Is Glycorex Transplantation's Earnings Per Share (TTM)?

The Glycorex Transplantation EPS (TTM) is -0.12.

From a Technical Analysis Perspective, Is GTABb a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Glycorex Transplantation Stock Split?

Glycorex Transplantation has split 3 times.

How Many Employees Does Glycorex Transplantation Have?

Glycorex Transplantation has 20 employees.

What is the current trading status of Glycorex Transplantation (GTABb)?

As of 31 Aug 2025, Glycorex Transplantation (GTABb) is trading at a price of 2.160, with a previous close of 2.13. The stock has fluctuated within a day range of 2.160 to 2.160, while its 52-week range spans from 1.150 to 4.400.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.